Resiquimod is widely utilized in research focused on:
Topical Immunotherapy: It is used in creams for treating skin conditions like actinic keratosis and superficial basal cell carcinoma, enhancing local immune response.
Vaccine Adjuvant: Resiquimod acts as an adjuvant in vaccines, improving the effectiveness of the immune response against various pathogens.
Antiviral Applications: It shows promise in treating viral infections, particularly in enhancing the immune system's ability to combat viruses like HPV.
Research in Oncology: Its immunomodulatory properties are being explored in cancer therapies, potentially improving outcomes by stimulating immune activity against tumors.
Dermatological Research: Used in studies to understand skin immune responses and develop new treatments for inflammatory skin diseases.
